3-[(dibenzylphosphono)oxymethyl] phenytoin or 5, 5-Diphenyl-3[(phosphoonoxy)methyl]-2,4-imidazolinedione dibenzyl ester
![3-[(dibenzylphosphono)oxymethyl] phenytoin or 5, 5-Diphenyl-3[(phosphoonoxy)methyl]-2,4-imidazolinedione dibenzyl ester](/46/product/49/79/53/DBF.jpg)
Product Description
J P N PHARMA PRIVATE LIMITED
-
IN -
2015On CPHI since
J P N PHARMA PRIVATE LIMITED
-
IN
-
2015On CPHI since
More Products from J P N PHARMA PRIVATE LIMITED (47)
-
Product Ibandronate Sodium
Osteoporosis Bulk Drug -
Product Ibandronic Acid
Intermediate of Ibandronate Sodium -
Product 3-(N-Methyl –N-Pentylamino) Propionic Acid Hydrochloride
Intermediate of Ibandronate Sodium -
Product Risedronate Sodium
Osteoporosis Bulk Drug -
Product Risedronic Acid
Intermediate of Risedronate Sodium -
Product Fosphenytoin Sodium
Antiepileptic Bulk Drug -
Product DiBenzyl Phosphate
Intermediate of Fosphenytoin Sodium and Fosaprepitant -
Product Potassium Dibenzyl Phosphate
Intermediate of Fosphenytoin Sodium -
Product Sodium DiBenzyl Phosphate
Intermediate of Fosphenytoin Sodium -
Product Silver DiBenzyl Phosphate
Intermediate of Fosphenytoin Sodium -
Product Dibenzylphosphoryl Chloride
Intermediate -
Product Alendronate Sodium
Osteoporosis Bulk Drug
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance